Alzheimer’s Association International Conference 2016 (AAIC) – July 24, 2016

Anavex-1-1666x833.png

Event: Poster presentation: New Exploratory Alzheimer’s Drug ANAVEX 2-73: Dose Dependent Clinical Cognitive Improvement Observed in Mini Mental State Examination (MMSE) and Other Cognitive Markers in a Phase 2a Study in Mild-to-Moderate Alzheimer’s Patients


Date/Time:Sunday, July 24, 2016; 9:30 a.m. to 10:30 a.m. EDT


Location: Hall D/E, Metro Toronto Convention Centre, Toronto, ON

1/0